|
1
|
Ke L: Mortality and incidence trends from
esophagus cancer in selected geographic areas of China circa
1970–90. Int J Cancer. 102:271–274. 2002.PubMed/NCBI
|
|
2
|
Yoon HH, Khan M, Shi Q, et al: The
prognostic value of clinical and pathologic factors in esophageal
adenocarcinoma: a mayo cohort of 796 patients with extended
follow-up after surgical resection. Mayo Clin Proc. 85:1080–1089.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bauer KR, Brown M, Cress RD, et al:
Descriptive analysis of estrogen receptor (ER)-negative,
progesterone receptor (PR)-negative, and HER2-negative invasive
breast cancer, the so-called triple-negative phenotype: a
population-based study from the California cancer Registry. Cancer.
109:1721–1728. 2007. View Article : Google Scholar
|
|
4
|
Raouf AA, Evoy DA, Carton E, Mulligan E,
Griffin MM and Reynolds JV: Loss of Bcl-2 expression in Barrett’s
dysplasia and adenocarcinoma is associated with tumor progression
and worse survival but not with response to neoadjuvant
chemoradiation. Dis Esophagus. 16:17–23. 2003.
|
|
5
|
Ito Y, Takeda T, Sasaki Y, et al: Bcl-2
expression in cholangiocellular carcinoma is inversely correlated
with biologically aggressive phenotypes. Oncology. 59:63–67. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kunnumakkara AB, Diagaradjane P, Guha S,
et al: Curcumin sensitizes human colorectal cancer xenografts in
nude mice to gamma-radiation by targeting nuclear
factor-kappaB-regulated gene products. Clin Cancer Res.
14:2128–2136. 2008. View Article : Google Scholar
|
|
7
|
Morselli E, Shen S, Ruckenstuhl C, et al:
p53 inhibits autophagy by interacting with the human ortholog of
yeast Atg17, RB1CC1/FIP200. Cell Cycle. 10:2763–2769. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Levine B: Cell biology: autophagy and
cancer. Nature. 446:745–747. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rouschop KM, Ramaekers CH, Schaaf MB, et
al: Autophagy is required during cycling hypoxia to lower
production of reactive oxygen species. Radiother Oncol. 92:411–416.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mathew R, Karp CM, Beaudoin B, et al:
Autophagy suppresses tumorigenesis through elimination of p62.
Cell. 137:1062–1075. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tey SK and Khanna R: Autophagy mediates
transporter associated with antigen processing-independent
presentation of viral epitopes through MHC class I pathway. Blood.
120:994–1004. 2012. View Article : Google Scholar
|
|
12
|
Hu YL, Jahangiri A, Delay M, et al: Tumor
cell autophagy as an adaptive response mediating resistance to
treatments such as antiangiogenic therapy. Cancer Res.
72:4294–4299. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He H, Dang Y, Dai F, et al:
Post-translational modifications of three members of the human
MAP1LC3 family and detection of a novel type of modification for
MAP1LC3B. J Biol Chem. 278:29278–29287. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sivridis E, Koukourakis MI, Mendrinos SE,
Touloupidis S and Giatromanolaki A: Patterns of autophagy in
urothelial cell carcinomas-the significance of ‘stone-like’
structures (SLS) in transurethral resection biopsies. Urol Oncol.
Jan 24–2012.(Epub ahead of print).
|
|
15
|
Karpathiou G, Sivridis E, Koukourakis MI,
et al: Light-chain 3A autophagic activity and prognostic
significance in non-small cell lung carcinomas. Chest. 140:127–134.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sivridis E, Giatromanolaki A, Liberis V
and Koukourakis MI: Autophagy in endometrial carcinomas and
prognostic relevance of ‘stone-like’ structures (SLS): what is
destined for the atypical endometrial hyperplasia? Autophagy.
7:74–82. 2011.PubMed/NCBI
|
|
17
|
Giatromanolaki A, Koukourakis MI, Harris
AL, Polychronidis A, Gatter KC and Sivridis E: Prognostic relevance
of light chain 3 (LC3A) autophagy patterns in colorectal
adenocarcinomas. J Clin Pathol. 63:867–872. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sivridis E, Giatromanolaki A, Karpathiou
G, Karpouzis A, Kouskoukis C and Koukourakis MI: LC3A-positive
‘stone-like’ structures in cutaneous squamous cell carcinomas. Am J
Dermatopathol. 33:285–290. 2011.
|
|
19
|
Hofseth LJ, Hussain SP and Harris CC: p53:
25 years after its discovery. Trends Pharmacol Sci. 25:177–181.
2004.
|
|
20
|
Sobin LH and Wittekind CH; International
Union against Cancer. TNM Classification of Malignant Tumors. 6th
ed. Wiley-Liss; New York: pp. 52–56. 2002
|
|
21
|
Ishida M, Morita M, Saeki H, et al:
Expression of p53 and p21 and the clinical response for
hyperthermochemoradiotherapy in patients with squamous cell
carcinoma of the esophagus. Anticancer Res. 27:3501–3506.
2007.PubMed/NCBI
|
|
22
|
Olivier M, Eeles R, Hollstein M, Khan MA,
Harris CC and Hainaut P: The IARC TP53 database: new online
mutation analysis and recommendations to users. Hum Mutat.
19:607–614. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han U, Can OI, Han S, Kayhan B and Onal
BU: Expressions of p53, VEGF C, p21: could they be used in
preoperative evaluation of lymph node metastasis of esophageal
squamous cell carcinoma? Dis Esophagus. 20:379–385. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Heeren PA, Kloppenberg FW, Hollema H,
Mulder NH, Nap RE and Plukker JT: Predictive effect of p53 and p21
alteration on chemotherapy response and survival in locally
advanced adenocarcinoma of the esophagus. Anticancer Res.
24:2579–2583. 2004.PubMed/NCBI
|
|
25
|
Taghavi N, Biramijamal F, Sotoudeh M, et
al: Association of p53/p21 expression with cigarette smoking and
prognosis in esophageal squamous cell carcinoma patients. World J
Gastroenterol. 16:4958–4967. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ressiot E, Dahan L, Liprandi A, et al:
Predictive factors of the response to chemoradiotherapy in
esophageal cancer. Gastroenterol Clin Biol. 32:567–577. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fujii S, Mitsunaga S, Yamazaki M, et al:
Autophagy is activated in pancreatic cancer cells and correlates
with poor patient outcome. Cancer Sci. 99:1813–1819.
2008.PubMed/NCBI
|
|
28
|
Sivridis E, Koukourakis MI, Mendrinos SE,
et al: Beclin-1 and LC3A expression in cutaneous malignant
melanomas: a biphasic survival pattern for beclin-1. Melanoma Res.
21:188–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee IH, Kawai Y, Fergusson MM, et al: Atg7
modulates p53 activity to regulate cell cycle and survival during
metabolic stress. Science. 336:225–228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Budanov AV and Karin M: p53 target genes
sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling.
Cell. 134:451–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xia HG, Zhang L, Chen G, et al: Control of
basal autophagy by calpain1 mediated cleavage of ATG5. Autophagy.
6:61–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moretti L, Cha YI, Niermann KJ and Lu B:
Switch between apoptosis and autophagy: radiation-induced
endoplasmic reticulum stress? Cell Cycle. 6:793–798. 2007.
View Article : Google Scholar : PubMed/NCBI
|
